Fluoropharma Medical Stock Analysis
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Fluoropharma Medical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Fluoropharma Medical is worth, separate from its market price. There are two main types of Fluoropharma Medical's stock analysis: fundamental analysis and technical analysis.
The Fluoropharma Medical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Fluoropharma Medical's ongoing operational relationships across important fundamental and technical indicators.
Fluoropharma |
Fluoropharma Pink Sheet Analysis Notes
The company recorded a loss per share of 0.08. Fluoropharma Medical had not issued any dividends in recent years. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Fluoropharma Medical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Fluoropharma Medical call Thomas Tulip at 973-744-1565 or check out https://www.fluoropharma.com.Fluoropharma Medical Investment Alerts
| Fluoropharma Medical generated a negative expected return over the last 90 days | |
| Fluoropharma Medical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (2.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Fluoropharma Medical currently holds about 24.72 K in cash with (880.12 K) of positive cash flow from operations. |
Fluoropharma Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fluoropharma Medical's market, we take the total number of its shares issued and multiply it by Fluoropharma Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Fluoropharma Medical technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Fluoropharma Medical Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Fluoropharma Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Fluoropharma Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Fluoropharma Medical Outstanding Bonds
Fluoropharma Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fluoropharma Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fluoropharma bonds can be classified according to their maturity, which is the date when Fluoropharma Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
About Fluoropharma Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Fluoropharma Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fluoropharma shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Fluoropharma Medical. By using and applying Fluoropharma Pink Sheet analysis, traders can create a robust methodology for identifying Fluoropharma entry and exit points for their positions.
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Fluoropharma Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Complementary Tools for Fluoropharma Pink Sheet analysis
When running Fluoropharma Medical's price analysis, check to measure Fluoropharma Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluoropharma Medical is operating at the current time. Most of Fluoropharma Medical's value examination focuses on studying past and present price action to predict the probability of Fluoropharma Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluoropharma Medical's price. Additionally, you may evaluate how the addition of Fluoropharma Medical to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |